Lifeline AED, ReviveR AED and Lifeforce AED 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Defibtech 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2011-05-04
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Press release
  • 원인
    Alert on voluntary recall and corrective action by defibtech on semi-automatic external defibrillators the department of health (dh) today (may 4) draws public's attention to a worldwide voluntary recall by a us medical device manufacturer, defibtech, regarding its ddu-100 series semi-automatic external defibrillators (aeds) because in some instances, the shock is cancelled during the charging process. corrective action involves software upgrading. the defibrillators are sold under the brand names of lifeline aed, reviver aed and lifeforce aed. a spokesman for dh remarked that the department's medical device control office came to learn of the above recall through its surveillance scheme. the spokesman then explained, "the defect may result in the defibrillators unable to provide therapy which may mean failure to resuscitate patients. moreover, the defect is not detectable by periodic self-test. however, according to information provided by the manufacturer, the odds of the occurrence of the defect are very very rare." so far, dh has not received any report of adverse incident arising from the defective devices. "therefore, defibtech recommends that customers can keep their devices in service until the company has performed the software upgrade. the latter can be performed at the location where the devices are deployed," the spokesman said. "dh understands that international regulatory authorities including uk's medicines and healthcare products regulatory agency and us' food and drug administration also find the proposed course of action acceptable." in hong kong, defibtech's record indicated that 82 affected devices have been distributed here. customers can check the nine-digit serial number on the back of the aeds against the list published by defibtech at www.Defibtech.Com/fa11 to see if their devices are affected. "after risk assessment, dh also concurs that those who possess the affected products can keep their devices and contact their distributor or the us manufacturer for software upgrade. further information on this issue can be obtained from defibtech's website at www.Defibtech.Com/news/20110429.Html," the spokesman stated. dh will be monitoring the progress of the corrective action closely. ends/wednesday, may 4, 2011.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Press release: Alert on voluntary recall and corrective action by Defibtech on semi-automatic external defibrillators
  • Manufacturer

Manufacturer